Dose-response analysis of locomotor activity and stereotypy in dopamine D3 receptor mutant mice following acute amphetamine
Accumulating evidence suggests that dopamine D3 receptor (D3R) stimulation is inhibitory to spontaneous and psychostimulant‐induced locomotion through opposition of concurrent D1R and D2R‐mediated signaling. To evaluate this model, we used homozygous D3R mutant mice and wild‐type controls to investi...
Saved in:
Published in | Synapse (New York, N.Y.) Vol. 60; no. 5; pp. 399 - 405 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
Hoboken
Wiley Subscription Services, Inc., A Wiley Company
01.10.2006
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Accumulating evidence suggests that dopamine D3 receptor (D3R) stimulation is inhibitory to spontaneous and psychostimulant‐induced locomotion through opposition of concurrent D1R and D2R‐mediated signaling. To evaluate this model, we used homozygous D3R mutant mice and wild‐type controls to investigate the role of the D3R in locomotor activity and stereotypy stimulated by acute amphetamine (AMPH) (0.2, 2.5, 5.0, 10.0 mg/kg). At the lowest dose tested (0.2 mg/kg), neither D3R mutant mice nor wild‐type mice exhibited measurable change in locomotor activity or stereotypy relative to their respective saline‐treated controls. D3R mutant mice exhibited a significantly greater increase in locomotor activity, but not stereotypy, relative to wild‐type mice in response to treatment with AMPH 2.5 mg/kg. AMPH‐induced locomotor activity and stereotypy were similar in both wild‐type and D3R mutant mice at both the 5.0 and 10 mg/kg AMPH doses. These findings provide further support for an inhibitory role for the D3R in AMPH‐induced locomotor activity, and demonstrate a more limited role for the D3R in modulating AMPH‐induced stereotypy. Synapse 60:399–405, 2006. © 2006 Wiley‐Liss, Inc. |
---|---|
Bibliography: | Department of Veterans Affairs Medical Research Service ark:/67375/WNG-5ZZ34P23-N ArticleID:SYN20315 National Institute of Drug Abuse - No. DA016778-01; No. DA11284; No. DA14644; No. DA17323 istex:75CE382C33DB2A49A1F0E815BCE4EE998DFB3513 ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Correspondence to: Robert McNamara, University of Cincinnati College of Medicine, 231 Albert Sabin Way, ML 0559, Cincinnati, OH, USA. E-mail: robert.mcnamara@psychiatry.uc.edu |
ISSN: | 0887-4476 1098-2396 |
DOI: | 10.1002/syn.20315 |